peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
Formulaciones y vehculos: El GHK-Cu se formula en diferentes tipos de vehculos cosmticos
Anyone pregnant or breastfeeding, given the total absence of safety data in that population
For those looking to learn how to safely administer peptide therapy, enrolling in a Peptide Course can provide expert guidance
I do have a banana smoothy each day ( 1 banana, 2 tablespoons raspberry yoghurt, some milk) - so hopefully this would offer me the potassium
Duta-Mare, M